Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

New England Journal of Medicine

Volumn 342, Issue 1, 2000, Pages 15-20

  Schrag, Stephanie J ^a   Zywicki, Sara ^a   Farley, Monica M ^b   Reingold, Arthur L ^c   Harrison, Lee H ^d   Lefkowitz, Lewis B ^e   Hadler, James L ^f   Danila, Richard ^g   Cieslak, Paul R ^h   Schuchat, Anne ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f CDC   (United States)

^g MINNESOTA DEPARTMENT OF HEALTH   (United States)

^h Department of Human Resources ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; CHILD; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NEWBORN DEATH; NEWBORN INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; UNITED STATES;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; MORTALITY; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; UNITED STATES;

EID: 0034610804     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200001063420103     Document Type: Article

References (27)

1. McCracken GH Jr. Group B streptococci: the new challenge in neonatal infections. J Pediatr 1973;82:703-6.
2. Franciosi RA, Knostman JD, Zimmerman RA. Group B streptococcal neonatal and infant infections. J Pediatr 1973;82:707-18.
3. Barton LL, Feigin RD, Lins R. Group B beta hemolytic streptococcal meningitis in infants. J Pediatr 1973;82:719-23.
4. Baker CJ, Barrett FF, Gordon RC, Yow MD. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr 1973; 82:724-9.
5. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ 1992;41(SS-6):25-32.
6. Decreasing incidence of perinatal group B streptococcal disease - United States, 1993-1995. MMWR Morb Mortal Wkly Rep 1997;46:473-7.
7. Jackson LA, Hilsdon R, Farley MM, et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med 1995;123:415-20.
8. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
9. Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV. Comparison of prevention strategies for neonatal group B streptococcal infection: a population-based economic analysis. JAMA 1993;270:1442-8.
10. Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CA Jr. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994;83:483-94.
11. Yancey MK, Duff P. An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection. Obstet Gynecol 1994;83:367-71.
12. Mohle-Boetani JC, Lieu TA, Ray GT, Escobar G. Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics. Pediatrics 1999;103:703-10.
13. American Academy of Pediatrics Committee on Infectious Diseases, Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) disease. Pediatrics 1997;99:489-96.
14. Committee on Obstetric Practice. Prevention of early-onset group B streptococcal disease in newborns. ACOG committee opinion. No. 173. Washington, D.C.: American College of Obstetricians and Gynecologists, 1996.
15. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morb Mortal Wkly Rep 1996;45:1-24. [Erratum, MMWR Morb Mortal Wkly Rep 1996;45:679.]
16. Healthy people 2010. Washington, D.C.: Department of Health and Human Services (in press).
17. Adoption of hospital policies for prevention of perinatal group B streptococcal disease - United States, 1997. MMWR Morb Mortal Wkly Rep 1998;47:665-70.
18. Dillon HC Jr, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr 1987;110:31-6.
19. Krohn MA, Hillier SL, Baker CJ. Maternal peripartum complications associated with vaginal group B streptococcal colonization. J Infect Dis 1999;179:1410-5.
20. Yancey MK, Duff P, Clark P, Kurtzer T, Frentzen BH, Kubilis P. Peripartum infection associated with vaginal group B streptococcal colonization. Obstet Gynecol 1994;84:816-9.
21. Locksmith GJ, Clark P, Duff P. Maternal and neonatal infection rates with three different protocols for prevention of group B streptococcal disease. Am J Obstet Gynecol 1999;180:416-22.
22. Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol 1998;179: 879-83.
23. Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 1998;42: 1517-9.
24. Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci isolates to clindamycin and ervthromycin. Obstet Gynecol 1998;92:258-61.
25. Robbins JB, Schneerson R, Vann WF, Bryla DA, Fattom A. Prevention of systemic infections caused by group B streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccines. Ann N Y Acad Sci 1995;754:68-82.
26. Baker CJ, Paoletti LC, Wessels MR, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999;179:142-50.
27. Schuchat A. Group B streptococcus. Lancet 1999;353:51-6.